+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Systemic Mastocytosis Treatment Market 2024-2028

  • PDF Icon

    Report

  • 209 Pages
  • October 2024
  • Region: Global
  • TechNavio
  • ID: 6020090
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The systemic mastocytosis treatment market is forecasted to grow by USD 157.1 million during 2023-2028, accelerating at a CAGR of 6.2% during the forecast period. The report on the systemic mastocytosis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth of aging population, increasing prevalence of blood cancer, and growing healthcare expenditure.

The systemic mastocytosis treatment market is segmented as below:

By Type

  • AK-002
  • BLU-285
  • Brentuximab vedotin
  • Crenolanib besylate
  • Others

By Route Of Administration

  • Oral
  • Injectables
  • Topical

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advancements in diagnostic technologies for systemic mastocytosis treatment as one of the prime reasons driving the systemic mastocytosis treatment market growth during the next few years. Also, development of new drugs for systemic mastocytosis treatment and growing adoption of targeted therapies for systemic mastocytosis treatment will lead to sizable demand in the market.

The report on the systemic mastocytosis treatment market covers the following areas:

  • Systemic Mastocytosis Treatment Market sizing
  • Systemic Mastocytosis Treatment Market forecast
  • Systemic Mastocytosis Treatment Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading systemic mastocytosis treatment market vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, AB Science SA, AdvaCare Pharma, BDR Pharmaceuticals Internationals Pvt. Ltd, Blueprint Medicines Corp., Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Lupin Ltd., NOVA PHARMA LLC, Novartis AG, Ono Pharmaceutical Co. Ltd., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Zydus Lifesciences Ltd. Also, the systemic mastocytosis treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Route of Administration
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
  • Overview on factors of disruption
2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
3.2 Market characteristics
  • Market characteristics analysis
3.3 Value chain analysis
  • Value Chain Analysis
4 Market Sizing
4.1 Market definition
  • Offerings of companies included in the market definition
4.2 Market segment analysis
  • Market segments
4.3 Market size 2023
4.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
5.1 Global Systemic Mastocytosis Treatment Market 2018 - 2022
  • Historic Market Size - Data Table on Global Systemic Mastocytosis Treatment Market 2018 - 2022 ($ million)
5.2 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
5.3 Route of Administration segment analysis 2018 - 2022
  • Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
5.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
5.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on the Global Systemic Mastocytosis Treatment Market
7 Five Forces Analysis
7.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
7.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Type
8.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
8.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
8.3 AK-002 - Market size and forecast 2023-2028
  • Chart on AK-002 - Market size and forecast 2023-2028 ($ million)
  • Data Table on AK-002 - Market size and forecast 2023-2028 ($ million)
  • Chart on AK-002 - Year-over-year growth 2023-2028 (%)
  • Data Table on AK-002 - Year-over-year growth 2023-2028 (%)
8.4 BLU-285 - Market size and forecast 2023-2028
  • Chart on BLU-285 - Market size and forecast 2023-2028 ($ million)
  • Data Table on BLU-285 - Market size and forecast 2023-2028 ($ million)
  • Chart on BLU-285 - Year-over-year growth 2023-2028 (%)
  • Data Table on BLU-285 - Year-over-year growth 2023-2028 (%)
8.5 Brentuximab vedotin - Market size and forecast 2023-2028
  • Chart on Brentuximab vedotin - Market size and forecast 2023-2028 ($ million)
  • Data Table on Brentuximab vedotin - Market size and forecast 2023-2028 ($ million)
  • Chart on Brentuximab vedotin - Year-over-year growth 2023-2028 (%)
  • Data Table on Brentuximab vedotin - Year-over-year growth 2023-2028 (%)
8.6 Crenolanib besylate - Market size and forecast 2023-2028
  • Chart on Crenolanib besylate - Market size and forecast 2023-2028 ($ million)
  • Data Table on Crenolanib besylate - Market size and forecast 2023-2028 ($ million)
  • Chart on Crenolanib besylate - Year-over-year growth 2023-2028 (%)
  • Data Table on Crenolanib besylate - Year-over-year growth 2023-2028 (%)
8.7 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
8.8 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Route of Administration
9.1 Market segments
  • Chart on Route of Administration - Market share 2023-2028 (%)
  • Data Table on Route of Administration - Market share 2023-2028 (%)
9.2 Comparison by Route of Administration
  • Chart on Comparison by Route of Administration
  • Data Table on Comparison by Route of Administration
9.3 Oral - Market size and forecast 2023-2028
  • Chart on Oral - Market size and forecast 2023-2028 ($ million)
  • Data Table on Oral - Market size and forecast 2023-2028 ($ million)
  • Chart on Oral - Year-over-year growth 2023-2028 (%)
  • Data Table on Oral - Year-over-year growth 2023-2028 (%)
9.4 Injectables - Market size and forecast 2023-2028
  • Chart on Injectables - Market size and forecast 2023-2028 ($ million)
  • Data Table on Injectables - Market size and forecast 2023-2028 ($ million)
  • Chart on Injectables - Year-over-year growth 2023-2028 (%)
  • Data Table on Injectables - Year-over-year growth 2023-2028 (%)
9.5 Topical - Market size and forecast 2023-2028
  • Chart on Topical - Market size and forecast 2023-2028 ($ million)
  • Data Table on Topical - Market size and forecast 2023-2028 ($ million)
  • Chart on Topical - Year-over-year growth 2023-2028 (%)
  • Data Table on Topical - Year-over-year growth 2023-2028 (%)
9.6 Market opportunity by Route of Administration
  • Market opportunity by Route of Administration ($ million)
  • Data Table on Market opportunity by Route of Administration ($ million)
10 Customer Landscape
10.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
11.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
11.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
11.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
11.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
11.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
11.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
11.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
11.8 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
11.9 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
11.10 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
11.11 France - Market size and forecast 2023-2028
  • Chart on France - Market size and forecast 2023-2028 ($ million)
  • Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Chart on France - Year-over-year growth 2023-2028 (%)
  • Data Table on France - Year-over-year growth 2023-2028 (%)
11.12 Spain - Market size and forecast 2023-2028
  • Chart on Spain - Market size and forecast 2023-2028 ($ million)
  • Data Table on Spain - Market size and forecast 2023-2028 ($ million)
  • Chart on Spain - Year-over-year growth 2023-2028 (%)
  • Data Table on Spain - Year-over-year growth 2023-2028 (%)
11.13 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
11.14 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
11.15 South Korea - Market size and forecast 2023-2028
  • Chart on South Korea - Market size and forecast 2023-2028 ($ million)
  • Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
  • Chart on South Korea - Year-over-year growth 2023-2028 (%)
  • Data Table on South Korea - Year-over-year growth 2023-2028 (%)
11.16 India - Market size and forecast 2023-2028
  • Chart on India - Market size and forecast 2023-2028 ($ million)
  • Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Chart on India - Year-over-year growth 2023-2028 (%)
  • Data Table on India - Year-over-year growth 2023-2028 (%)
11.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
12.4 Market opportunities/restraints
13 Competitive Landscape
13.1 Overview
13.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
  • Overview on factors of disruption
13.4 Industry risks
  • Impact of key risks on business
14 Competitive Analysis
14.1 Companies profiled
  • Companies covered
14.2 Company ranking index
  • Company ranking index
14.3 Market positioning of companies
  • Matrix on companies position and classification
14.4 A. Menarini Industrie Farmaceutiche Riunite Srl
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
  • SWOT
14.5 Blueprint Medicines Corp.
  • Blueprint Medicines Corp. - Overview
  • Blueprint Medicines Corp. - Product / Service
  • Blueprint Medicines Corp. - Key news
  • Blueprint Medicines Corp. - Key offerings
  • SWOT
14.6 Dr Reddys Laboratories Ltd.
  • Dr Reddys Laboratories Ltd. - Overview
  • Dr Reddys Laboratories Ltd. - Business segments
  • Dr Reddys Laboratories Ltd. - Key news
  • Dr Reddys Laboratories Ltd. - Key offerings
  • Dr Reddys Laboratories Ltd. - Segment focus
  • SWOT
14.7 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
14.8 Glenmark Pharmaceuticals Ltd.
  • Glenmark Pharmaceuticals Ltd. - Overview
  • Glenmark Pharmaceuticals Ltd. - Product / Service
  • Glenmark Pharmaceuticals Ltd. - Key offerings
  • SWOT
14.9 Intas Pharmaceuticals Ltd.
  • Intas Pharmaceuticals Ltd. - Overview
  • Intas Pharmaceuticals Ltd. - Product / Service
  • Intas Pharmaceuticals Ltd. - Key offerings
  • SWOT
14.10 Lupin Ltd.
  • Lupin Ltd. - Overview
  • Lupin Ltd. - Business segments
  • Lupin Ltd. - Key news
  • Lupin Ltd. - Key offerings
  • Lupin Ltd. - Segment focus
  • SWOT
14.11 NOVA PHARMA LLC
  • NOVA PHARMA LLC - Overview
  • NOVA PHARMA LLC - Product / Service
  • NOVA PHARMA LLC - Key offerings
  • SWOT
14.12 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
  • SWOT
14.13 Ono Pharmaceutical Co. Ltd.
  • Ono Pharmaceutical Co. Ltd. - Overview
  • Ono Pharmaceutical Co. Ltd. - Product / Service
  • Ono Pharmaceutical Co. Ltd. - Key offerings
  • SWOT
14.14 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
14.15 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
  • SWOT
14.16 Sun Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Product / Service
  • Sun Pharmaceutical Industries Ltd. - Key news
  • Sun Pharmaceutical Industries Ltd. - Key offerings
  • SWOT
14.17 Takeda Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Takeda Pharmaceutical Co. Ltd. - Key news
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
  • SWOT
14.18 Zydus Lifesciences Ltd.
  • Zydus Lifesciences Ltd. - Overview
  • Zydus Lifesciences Ltd. - Business segments
  • Zydus Lifesciences Ltd. - Key news
  • Zydus Lifesciences Ltd. - Key offerings
  • Zydus Lifesciences Ltd. - Segment focus
  • SWOT
15 Appendix
15.1 Scope of the report
15.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
15.3 Currency conversion rates for US$
  • Currency conversion rates for US$
15.4 Research methodology
  • Research methodology
15.5 Data procurement
  • Information sources
15.6 Data validation
  • Data validation
15.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
15.8 Data synthesis
  • Data synthesis
15.9 360 degree market analysis
  • 360 degree market analysis
15.10 List of abbreviations
  • List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 11: Overview on criticality of inputs and factors of differentiation
Exhibits 12: Overview on factors of disruption
Exhibits 13: Impact of drivers and challenges in 2023 and 2028
Exhibits 14: Parent Market
Exhibits 15: Data Table on - Parent Market
Exhibits 16: Market characteristics analysis
Exhibits 17: Value Chain Analysis
Exhibits 18: Offerings of companies included in the market definition
Exhibits 19: Market segments
Exhibits 20: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 21: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 22: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 23: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 24: Historic Market Size - Data Table on Global Systemic Mastocytosis Treatment Market 2018 - 2022 ($ million)
Exhibits 25: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 26: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits 27: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 28: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 29: Five forces analysis - Comparison between 2023 and 2028
Exhibits 30: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 31: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 32: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 33: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 34: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 35: Chart on Market condition - Five forces 2023 and 2028
Exhibits 36: Chart on Type - Market share 2023-2028 (%)
Exhibits 37: Data Table on Type - Market share 2023-2028 (%)
Exhibits 38: Chart on Comparison by Type
Exhibits 39: Data Table on Comparison by Type
Exhibits 40: Chart on AK-002 - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on AK-002 - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on AK-002 - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on AK-002 - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on BLU-285 - Market size and forecast 2023-2028 ($ million)
Exhibits 45: Data Table on BLU-285 - Market size and forecast 2023-2028 ($ million)
Exhibits 46: Chart on BLU-285 - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on BLU-285 - Year-over-year growth 2023-2028 (%)
Exhibits 48: Chart on Brentuximab vedotin - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Data Table on Brentuximab vedotin - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Chart on Brentuximab vedotin - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Brentuximab vedotin - Year-over-year growth 2023-2028 (%)
Exhibits 52: Chart on Crenolanib besylate - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on Crenolanib besylate - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on Crenolanib besylate - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Crenolanib besylate - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 60: Market opportunity by Type ($ million)
Exhibits 61: Data Table on Market opportunity by Type ($ million)
Exhibits 62: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits 63: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits 64: Chart on Comparison by Route of Administration
Exhibits 65: Data Table on Comparison by Route of Administration
Exhibits 66: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 69: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 70: Chart on Injectables - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Data Table on Injectables - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Chart on Injectables - Year-over-year growth 2023-2028 (%)
Exhibits 73: Data Table on Injectables - Year-over-year growth 2023-2028 (%)
Exhibits 74: Chart on Topical - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Data Table on Topical - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Chart on Topical - Year-over-year growth 2023-2028 (%)
Exhibits 77: Data Table on Topical - Year-over-year growth 2023-2028 (%)
Exhibits 78: Market opportunity by Route of Administration ($ million)
Exhibits 79: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 80: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 81: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 82: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 83: Chart on Geographic comparison
Exhibits 84: Data Table on Geographic comparison
Exhibits 85: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 109: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 110: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 111: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 112: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 113: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 114: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 115: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 116: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 117: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 118: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 119: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 120: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 121: Chart on Spain - Market size and forecast 2023-2028 ($ million)
Exhibits 122: Data Table on Spain - Market size and forecast 2023-2028 ($ million)
Exhibits 123: Chart on Spain - Year-over-year growth 2023-2028 (%)
Exhibits 124: Data Table on Spain - Year-over-year growth 2023-2028 (%)
Exhibits 125: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 126: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 127: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 128: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 129: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 130: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 131: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 132: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 133: Chart on South Korea - Market size and forecast 2023-2028 ($ million)
Exhibits 134: Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
Exhibits 135: Chart on South Korea - Year-over-year growth 2023-2028 (%)
Exhibits 136: Data Table on South Korea - Year-over-year growth 2023-2028 (%)
Exhibits 137: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits 138: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits 139: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits 140: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits 141: Market opportunity By Geographical Landscape ($ million)
Exhibits 142: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 143: Impact of drivers and challenges in 2023 and 2028
Exhibits 144: Overview on criticality of inputs and factors of differentiation
Exhibits 145: Overview on factors of disruption
Exhibits 146: Impact of key risks on business
Exhibits 147: Companies covered
Exhibits 148: Company ranking index
Exhibits 149: Matrix on companies position and classification
Exhibits 150: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
Exhibits 151: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
Exhibits 152: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
Exhibits 153: SWOT
Exhibits 154: Blueprint Medicines Corp. - Overview
Exhibits 155: Blueprint Medicines Corp. - Product / Service
Exhibits 156: Blueprint Medicines Corp. - Key news
Exhibits 157: Blueprint Medicines Corp. - Key offerings
Exhibits 158: SWOT
Exhibits 159: Dr Reddys Laboratories Ltd. - Overview
Exhibits 160: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 161: Dr Reddys Laboratories Ltd. - Key news
Exhibits 162: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 163: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 164: SWOT
Exhibits 165: F. Hoffmann La Roche Ltd. - Overview
Exhibits 166: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 167: F. Hoffmann La Roche Ltd. - Key news
Exhibits 168: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 169: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 170: SWOT
Exhibits 171: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits 172: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits 173: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits 174: SWOT
Exhibits 175: Intas Pharmaceuticals Ltd. - Overview
Exhibits 176: Intas Pharmaceuticals Ltd. - Product / Service
Exhibits 177: Intas Pharmaceuticals Ltd. - Key offerings
Exhibits 178: SWOT
Exhibits 179: Lupin Ltd. - Overview
Exhibits 180: Lupin Ltd. - Business segments
Exhibits 181: Lupin Ltd. - Key news
Exhibits 182: Lupin Ltd. - Key offerings
Exhibits 183: Lupin Ltd. - Segment focus
Exhibits 184: SWOT
Exhibits 185: NOVA PHARMA LLC - Overview
Exhibits 186: NOVA PHARMA LLC - Product / Service
Exhibits 187: NOVA PHARMA LLC - Key offerings
Exhibits 188: SWOT
Exhibits 189: Novartis AG - Overview
Exhibits 190: Novartis AG - Business segments
Exhibits 191: Novartis AG - Key news
Exhibits 192: Novartis AG - Key offerings
Exhibits 193: Novartis AG - Segment focus
Exhibits 194: SWOT
Exhibits 195: Ono Pharmaceutical Co. Ltd. - Overview
Exhibits 196: Ono Pharmaceutical Co. Ltd. - Product / Service
Exhibits 197: Ono Pharmaceutical Co. Ltd. - Key offerings
Exhibits 198: SWOT
Exhibits 199: Pfizer Inc. - Overview
Exhibits 200: Pfizer Inc. - Product / Service
Exhibits 201: Pfizer Inc. - Key news
Exhibits 202: Pfizer Inc. - Key offerings
Exhibits 203: SWOT
Exhibits 204: Sanofi SA - Overview
Exhibits 205: Sanofi SA - Business segments
Exhibits 206: Sanofi SA - Key news
Exhibits 207: Sanofi SA - Key offerings
Exhibits 208: Sanofi SA - Segment focus
Exhibits 209: SWOT
Exhibits 210: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 211: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 212: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits 213: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 214: SWOT
Exhibits 215: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 216: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 217: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 218: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 219: SWOT
Exhibits 220: Zydus Lifesciences Ltd. - Overview
Exhibits 221: Zydus Lifesciences Ltd. - Business segments
Exhibits 222: Zydus Lifesciences Ltd. - Key news
Exhibits 223: Zydus Lifesciences Ltd. - Key offerings
Exhibits 224: Zydus Lifesciences Ltd. - Segment focus
Exhibits 225: SWOT
Exhibits 226: Inclusions checklist
Exhibits 227: Exclusions checklist
Exhibits 228: Currency conversion rates for US$
Exhibits 229: Research methodology
Exhibits 230: Information sources
Exhibits 231: Data validation
Exhibits 232: Validation techniques employed for market sizing
Exhibits 233: Data synthesis
Exhibits 234: 360 degree market analysis
Exhibits 235: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global systemic mastocytosis treatment market: A. Menarini Industrie Farmaceutiche Riunite Srl, AB Science SA, AdvaCare Pharma, BDR Pharmaceuticals Internationals Pvt. Ltd, Blueprint Medicines Corp., Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Lupin Ltd., NOVA PHARMA LLC, Novartis AG, Ono Pharmaceutical Co. Ltd., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Zydus Lifesciences Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advancements in diagnostic technologies for systemic mastocytosis treatment."

According to the report, one of the major drivers for this market is the growth of aging population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • AB Science SA
  • AdvaCare Pharma
  • BDR Pharmaceuticals Internationals Pvt. Ltd
  • Blueprint Medicines Corp.
  • Dr Reddys Laboratories Ltd.
  • F. Hoffmann La Roche Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Lupin Ltd.
  • NOVA PHARMA LLC
  • Novartis AG
  • Ono Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Zydus Lifesciences Ltd.

Related Topics

Related Reports

Systemic Mastocytosis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Systemic Mastocytosis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 91 Pages
  • Global
From
Rosacea Treatment Market 2024-2028 - Product Image

Rosacea Treatment Market 2024-2028

  • Report
  • 170 Pages
  • Global
From
Inflammatory Bowel Disease Market 2024-2028 - Product Image

Inflammatory Bowel Disease Market 2024-2028

  • Report
  • 170 Pages
  • Global
From
Inflammatory Bowel Disease Treatment Global Market Report 2024 - Product Image

Inflammatory Bowel Disease Treatment Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Ankylosing Spondylitis Global Market Report 2024 - Product Image

Ankylosing Spondylitis Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.